As of Q4'25, CMG reported a diluted EPS of 0.25 USD, with year-over-year EPS growth at 4.2%. This marks a slight decrease from the previous quarter’s EPS of 0.29 USD, but a modest improvement in growth compared to Q2'25, which saw negative YoY growth. From Q1'23 to Q4'25, CMG’s diluted EPS demonstrated a generally upward trend with some volatility, peaking at 0.33 USD in Q2'24. Year-over-year EPS growth was strongest in Q1'23 at 87.5%, but gradually moderated over the period, even turning slightly negative in Q2'25 before recovering. Overall, the data reflects a phase of strong initial growth followed by stabilization, with recent quarters showing more moderate and consistent performance.